Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 22, 2018 08:27 ET | Source: Precipio, Inc.

Precipio Commences Validation Study of Proprietary IV-Cell Cytogenetics Media at University of Pennsylvania

NEW HAVEN, Conn., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics firm Precipio, Inc. (NASDAQ:PRPO), today announced it is collaborating with the cytogenetics laboratory at the University of...